Literature DB >> 10872133

Clostridium difficile-associated diseases. The clinical courses of 18 fatal cases.

M Siemann1, M Koch-Dörfler, G Rabenhorst.   

Abstract

OBJECTIVE: Severe cases of Clostridium difficile-associated diseases with sepsis seem to be rare, as are case reports about the pathogen involved and sepsis. Our objective was to investigate the frequency and the clinical courses of severe cases of C. difficile-associated diseases with a fatal outcome in our hospital.
SETTING: Teaching hospital of the University of Kiel (650 beds).
DESIGN: We reviewed retrospectively all deceased patients' charts who had prior histological or microbiological evidence of C. difficile-associated diarrhea (CDAD) and revised the available histological specimens of the autopsies. PATIENTS: Over a 4-year period (November 1994-October 1998) we diagnosed 304 cases of C. difficile-associated diseases in our hospital.
RESULTS: Eighteen of our cases with C. difficile-associated diseases had a fatal outcome. C. difficile was not likely to be the cause of death in two of the cases. Four of the fatal infections were community-acquired and the reason for admission to the hospital. CDAD is most prevalent in elderly patients with multiple or severe underlying diseases and tends to be overlooked. Sepsis was diagnosed in 15 of our 18 patients with C. difficile-associated diseases.
CONCLUSION: Our study shows that severe cases of CDAD or cases with C. difficile-associated sepsis are probably not rare. Routine testing of fecal specimens for the presence of C. difficile toxins should be considered not only in nosocomial gastrointestinal infections but also in community-acquired gastrointestinal infections of elderly people.

Entities:  

Mesh:

Year:  2000        PMID: 10872133     DOI: 10.1007/s001340051175

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

1.  Surgical management of fulminant pseudomembranous colitis.

Authors:  A Boyer; G Thiery; E Pigne; A De Lassence
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

2.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

3.  Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.

Authors:  Yafet Mamo; Michael H Woodworth; Tiffany Wang; Tanvi Dhere; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

4.  Pathology of fatal traumatic and nontraumatic clostridial gas gangrene: a histopathological, immunohistochemical, and ultrastructural study of six autopsy cases.

Authors:  Michael Tsokos; Sarah Schalinski; Friedrich Paulsen; Jan P Sperhake; Klaus Püschel; Ingo Sobottka
Journal:  Int J Legal Med       Date:  2007-03-17       Impact factor: 2.686

5.  High mobility group box1 protein is involved in acute inflammation induced by Clostridium difficile toxin A.

Authors:  Ji Liu; Bei-Lei Zhang; Chun-Li Sun; Jun Wang; Shan Li; Ju-Fang Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-05-04       Impact factor: 3.848

6.  Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008.

Authors:  Kerrie E VerLee; Jennie L Finks; Melinda J Wilkins; Eden V Wells
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

7.  Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection.

Authors:  Zhiyong Yang; Lianfa Shi; Hua Yu; Yongrong Zhang; Kevin Chen; Ashley Saint Fleur; Guang Bai; Hanping Feng
Journal:  Pathog Dis       Date:  2016-08-07       Impact factor: 3.166

8.  An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins.

Authors:  Xiangyun He; Jufang Wang; Jennifer Steele; Xingmin Sun; Weijia Nie; Saul Tzipori; Hanping Feng
Journal:  J Microbiol Methods       Date:  2009-04-23       Impact factor: 2.363

9.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

10.  ICD-9 codes and surveillance for Clostridium difficile-associated disease.

Authors:  Erik R Dubberke; Kimberly A Reske; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.